$130M private equity deal to unite 3 GI practices, create 7th largest group in US

Written by Eric Oliver | May 30, 2019 | Print  |

Regional GI, Main Line Gastroenterology Associates and Digestive Disease Associates will merge in a $130 million deal with private equity firm Amulet Capital, PE Hub reports.

What you should know:

1. Amulet Capital is uniting the groups through the deal, creating the 7th largest GI physician group in the U.S. The deal follows analyst predictions that PE firms would target midsize GI groups.

2. Regional GI has four Pennsylvania locations in Lancaster, Elizabethtown and Ephrata and 23 clinicians.

3. Malvern, Pa.-based Main Line Gastroenterology Associates has seven offices, three endoscopy centers and 20 clinicians.

4. Wyomissing, Pa.-based Digestive Disease Associates has four practices, two surgery centers and 19 clinicians.

5. Amulet's deal is the fourth such in gastroenterology. Several analysts predicted a significant boom in GI-focused PE investment in 2019.

More articles on gastroenterology: 
The biggest opportunities for ASC revenue growth in the next 10 years
The future is bright for total joint replacement – 5 trends for ASCs to watch
The 3 revenue cycle benchmarks ASCs should know

© Copyright ASC COMMUNICATIONS 2019. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.

To receive the latest hospital and health system business and legal news and analysis from Becker's Hospital Review, sign-up for the free Becker's Hospital Review E-weekly by clicking here.